PA5-100993

antibody from Invitrogen Antibodies

Targeting: RGR RP44

Provider product page for PA5-100993

Western blot

Immunohistochemistry

Other assay

Antibody data

Antibody Data
Antigen structure
References [1]
Comments [0]
Validations
Other assay [5]

Submit

Product number: PA5-100993 - Provider product page
Provider: Invitrogen Antibodies
Product name: RGR Polyclonal Antibody
Antibody type: Polyclonal
Antigen: Synthetic peptide
Description: Antibody detects endogenous levels of total RGR.
Reactivity: Human
Host: Rabbit
Isotype: IgG
Vial size: 100 µL
Concentration: 1 mg/mL
Storage: -20°C

RGR protein structure - PA5-100993 shown in red.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: FIGURE 1 RGR expression in human skin tissue. Immunohistochemical methods were used to show positive RGR staining in the epithelial layer (yellow arrow), sebaceous gland (black arrow), hair follicle (orange arrow), sweat gland (red arrow), and blood vessel (blue arrow) of skin tissue. Scale bar = 500 mum.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: FIGURE 2 RGR expression level and subcellular localization in human skin cells. (A) In normal human skin tissue, coimmunostaining of RGR (red) with the melanocyte marker melan-A (green) and keratinocyte marker P-CK (pink) is shown. Scale bar = 20 mum. The results showed positive staining of the RGR in the basal layer of the skin, large sudoriferous glands, hair follicles, and eccrine glands. Scale bar = 200 mum. (B) Representative expression of RGR and beta -tubulin (loading control) in melanocytes, keratinocytes, and fibroblasts, as measured by the Western blot assay (anti-RGR antibody: a band of ~32 kDa; beta -tubulin antibody: a band of ~55 kDa). The relative protein levels of RGR and beta -tubulin were measured by ImageJ software (n = 3 independent experiments). (C) In cultured cells, the colocalization of the RGR (green) and melan-A (red) in melanocytes, colocalization of RGR (green) and CK-pan (red) in keratinocytes, and colocalization of RGR (green) and vimentin (red) in fibroblasts were detected by immunofluorescence double staining. Scale bar = 20 mum. (D) Localization and expression of the RGR (green) in human skin cells (melanocytes, keratinocytes, and fibroblasts) were observed by a confocal microscope. Scale bar = 20 mum. (E) IEM staining of the normal skin tissue. Representative protein A-gold probe represents RGR (RGR is mainly located in the nucleoplasm (yellow arrow) and mitochondria (red arrow) and scattered in the cytoplasm and other organelles (black arrow

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: FIGURE 3 UVA and UVR may not induce RGR expression in human keratinocytes. (A) The differential RGR expression in the exposed and unexposed skin tissues was analyzed by immunohistochemistry. The RGR was highly expressed in the epithelial layer of light-exposed sites, particularly in the basal cell layer and spinous cell layer of the epidermis and cells of the skin appendages. Exposed area vs unexposed area, * p < 0.05. Scale bar = 100 mum (right), 50 mum (middle), 20 mum (left). (B) Keratinocytes with all-trans-retinal were irradiated with 3 J/cm 2 UVA. Representative expression of RGR and beta -tubulin (loading control) by Western blot analysis. The relative protein levels of RGR and beta -tubulin were measured using ImageJ software (n = 3 independent experiments). (C) Keratinocytes with all-trans-retinal were irradiated with 1.5 J/cm 2 UVR. Representative expression of RGR and beta -tubulin (loading control) was detected by Western blot analysis. The relative protein levels of RGR and beta -tubulin were measured using ImageJ software (n = 3 independent experiments).

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: FIGURE 4 RGR is highly expressed in proliferative diseases and tumor tissues. (A) RGR expression (red) is colocalized with the proliferative marker PCNA (green) in psoriasis, seborrheic keratosis, and squamous cell carcinoma. Scale bar = 20 mum. (B) Representative expression of RGR and beta -tubulin (loading control) in lesion areas and non-lesion areas was detected by WB analysis. The relative protein levels of RGR and beta -tubulin were measured using ImageJ software (n = 3 independent experiments). * p < 0.05. (C) Representative expression of PCNA and beta -tubulin (loading control) was detected by WB analysis. The relative protein levels of RGR and beta -tubulin were measured using ImageJ software (n = 3 independent experiments). ** p < 0.01.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: FIGURE 5 RGR regulates the proliferation, migration, and apoptosis of keratinocytes. (A) Representative keratinocyte defects in RGR (with small siRNA) and beta -tubulin (loading control) were detected by WB analysis. The relative protein levels of RGR and beta -tubulin were measured using ImageJ software (n = 3 independent experiments). * p < 0.05, ** p < 0.01, *** p < 0.001. (B) Representative images of cell fragmentation and cell contraction observed under a light microscope in the si-RGR transfection group. No significant morphological change was detected in the si-control group. Scale bar = 20 mum * p < 0.05, ** p < 0.01, *** p < 0.001 vs the control group. (C) Flow cytometry with annexin V FITC/PI double staining was used to determine apoptotic cells. Following RGR knockdown, a significant decrease in apoptosis was detected in the keratinocytes transfected with si-RGR compared with the control. * p < 0.05, ** p < 0.01, *** p < 0.001 vs the control group. (D) Flow cytometry was used to detect the cell cycle after RGR knockdown in keratinocytes. Following RGR knockdown, a significant decrease in the S phase at 48 h was detected in keratinocytes transfected with si-RGR compared with the control. * p < 0.05 vs the control group. (E) RGR in keratinocytes was inhibited via Si-RGR, and cell viability was measured after 48 h. (F) Representative images from wound healing experiments showed low expression of the RGR and decreased mobility relative to controls. Scale bar = 50 mum *